Home
company

Avenue Therapeutics Inc

Cipla subsidiary gets termination notice on $215 million deal with US firm Avenue Therapeutics

Healthcare

03 November, 2021

Cipla subsidiary gets termination notice on $215 million deal with US firm Avenue Therapeutics

Indian drugmaker Cipla Ltd said its subsidiary InvaGen Pharmaceuticals has received a notice of termination on a three year old ......

Joseph Rai

Cipla to acquire US-based speciality drugmaker Avenue Therapeutics

Healthcare

13 November, 2018

Cipla to acquire US-based speciality drugmaker Avenue Therapeutics

Indian drugmaker Cipla Ltd said Tuesday it has signed pacts to acquire Nasdaq-listed speciality pharmaceutical company Avenue Therapeutics Inc. for ......

Joseph Rai

Recommended for you

Premium

Avenue Therapeutics Inc

Healthcare

Cipla subsidiary gets termination notice on $215 million deal with US firm Avenue Therapeutics

Healthcare

Cipla to acquire US-based speciality drugmaker Avenue Therapeutics

Recommended for you

TMT

Jagran Group FO's Aarti Gupta on their investment strategy, caution on private market and more

Finance

Swiggy backer Norwest Venture Partners raises $3 bn global fund

TMT

SoftBank, TPG-backed FirstCry set to withdraw IPO papers after SEBI scrutiny

Infrastructure

Edelweiss Alts buys second asset from office segment-focused fund

TMT

Saudi PIF, STC Group likely to bid for Spanish Cellnex's Austrian unit

Finance

Saudi Arabia's PIF hits $749 bn in assets under management